Treatment for bacterial overgrowth in the irritable bowel syndrome.
Ann Intern Med. 2006;145(8):626-628.
Halvorson HA, Schlett CD, Riddle MS.
Postinfectious irritable bowel syndrome—a meta-analysis.
Am J Gastroenterol. 2006;101(8):1894-1899.
Irritable bowel syndrome.
American Society of Colon and Rectal Surgeons website. Available at:
https://www.fascrs.org/patients/disease-condition/irritable-bowel-syndrome-0. Update October 2012. Accessed December 19, 2014.
Irritable bowel syndrome.
National Institute of Diabetes and Digestive and Kidney Diseases website. Available at:
http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/irritable-bowel-syndrome/Pages/overview.aspx. Updated June 25, 2014. Accessed December 19, 2014.
Murch S. Allergy and intestinal dysmotility—evidence of genuine causal linkage?
Curr Opin Gastroenterol. 2006;22(6):664-668.
Rubin G, De Wit N, Meineche-Schmidt V, et al.
The diagnosis of IBS in primary care: consensus development using nominal group technique.
Family Practitioner. Fam Pract. 2006;23(6):687-692.
Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study.
Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea.
Curr Opin Clin Nutr Metab Care. 2006;9(6):717-721.
9/26/2006 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Mueller-Lissner S, Tytgat GN, Paulo LG, et al. Placebo-and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain.
Aliment Pharmacol Ther. 2006;23(12):1741-1748.
4/10/2007 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: US Food and Drug Administration. FDA announces discontinued marketing of GI drug, Zelnorm, for safety reasons. March 30, 2007. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108879.htm. Accessed December 19, 2014.
1/11/2010 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC. Clinical trial: efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome: results of a randomized, double-blind, placebo-controlled study.
Aliment Pharmacol Ther.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.